Thyroid cancers exhibit oncogene-enhanced macropinocytosis that is restrained by IGF1R and promotes albumin-drug-conjugate response.
Hui-Yu HuThomas S C NgMikyung KangElla ScottRan LiJeremy M QuintanaDylan MatveyVenkata R VantakuRalph WeisslederSareh ParangiMiles A MillerPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
These findings identify regulated oncogene-driven macropinocytosis in thyroid cancers and demonstrate the potential of designing albumin-bound drugs to efficiently treat them.